Working out of Copenhagen, with presence in San Francisco, Boston and Singapore, Novo Holdings is a world-leading life science investor with a focus on creating long-term value
Our mission is to be a supportive owner of the Novo Group companies and to make a growing and positive impact on health, science and society by generating attractive long-term returns on the assets of the Novo Nordisk Foundation.
We are the holding company of the Novo Group and manage the wealth of the Novo Nordisk Foundation. We invest in life science companies at all stages of development and in a broad portfolio of equity and fixed income securities. For more information, download our fact sheet.
Novo Holdings employs investment and business professionals focused on delivering attractive returns for the benefit of the Novo Nordisk Foundation.
Total assets of Novo Holdings at the end of 2019.
Return on Life Science investments (IRR) last 5 years.
Return on Financial investments (IRR) last 5 years.
Novo Holdings A/S
Tuborg Havnevej 19
2900 Hellerup
Denmark
+45 3527 6500
CVR# 24257630
Novo Ventures (US) Inc.*
200 Clarendon Street, Floor 45
Boston, MA 02116
USA
Novo Ventures (US) Inc.*
501 2nd Street, Suite 300
San Francisco, CA 94107
USA
+1 (415) 552-6686
Media Relations
Christian Mostrup Scheel
Senior Press Officer
cims@novo.dk
+45 3067 4805
*Novo Ventures (US) Inc. is a separate legal entity that provides certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts. Privacy notice › Whistleblower › Electronic invoicing ›